Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

Prevalence, treatment utilization described for hypertension, diabetes mellitus, obesity, LDL-C, and cigarette smoking.

Quality communication about end-of-life care ensures that medical treatments or interventions align with patients’ values and ...

Sodium-glucose cotransporter 2 inhibitors (eg, dapagliflozin) are understudied in kidney transplant recipients. A trial attempted to fill this knowledge gap.

After adjustment, light physical activity significantly linked to lower mortality in cardiovascular-kidney-metabolic syndrome ...

A survey of practices that treat AYA patients with cancer showed that almost half of them screen for financial hardship, but few offer cancer-specific navigation. A survey of practices that treat AYAs ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.

Highest risk seen for those with both physical frailty and depression; significant additive interaction also seen.

(HealthDay News) — A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including death, dementia, and myocardial infarction (MI), according ...

Investigators compared the risk of cancer onset in patients with lupus nephritis treatedwith calcineurin inhibitors vs ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.